TY - JOUR AU - Yeo, C. J. J. AU - Darras, B. T. PY - 2020 DA - 2020// TI - Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease JO - Pediatr Neurol UR - https://doi.org/10.1016/j.pediatrneurol.2020.01.003 DO - 10.1016/j.pediatrneurol.2020.01.003 ID - Yeo2020 ER - TY - JOUR AU - Chiriboga, C. A. AU - Swoboda, K. J. AU - Darras, B. T. AU - Iannaccone, S. T. AU - Montes, J. AU - Vivo, D. C. PY - 2016 DA - 2016// TI - Results from a phase 1 study of nusinersen (ISIS-SMN (Rx)) in children with spinal muscular atrophy JO - Neurology VL - 86 UR - https://doi.org/10.1212/WNL.0000000000002445 DO - 10.1212/WNL.0000000000002445 ID - Chiriboga2016 ER - TY - JOUR AU - Finkel, R. S. AU - Chiriboga, C. A. AU - Vajsar, J. AU - Day, J. W. AU - Montes, J. AU - Vivo, D. C. PY - 2016 DA - 2016// TI - Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study JO - Lancet Lond Engl VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31408-8 DO - 10.1016/S0140-6736(16)31408-8 ID - Finkel2016 ER - TY - JOUR AU - Finkel, R. S. AU - Mercuri, E. AU - Darras, B. T. AU - Connolly, A. M. AU - Kuntz, N. L. AU - Kirschner, J. PY - 2017 DA - 2017// TI - Nusinersen versus sham control in infantile-onset spinal muscular atrophy JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1702752 DO - 10.1056/NEJMoa1702752 ID - Finkel2017 ER - TY - JOUR AU - Mercuri, E. AU - Darras, B. T. AU - Chiriboga, C. A. AU - Day, J. W. AU - Campbell, C. AU - Connolly, A. M. PY - 2018 DA - 2018// TI - Nusinersen versus sham control in later-onset spinal muscular atrophy JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1710504 DO - 10.1056/NEJMoa1710504 ID - Mercuri2018 ER - TY - JOUR AU - Audic, F. AU - Banda, M. G. G. AU - Bernoux, D. AU - Ramirez-Garcia, P. AU - Durigneux, J. AU - Barnerias, C. PY - 2020 DA - 2020// TI - Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study JO - Orphanet J Rare Dis VL - 15 UR - https://doi.org/10.1186/s13023-020-01414-8 DO - 10.1186/s13023-020-01414-8 ID - Audic2020 ER - TY - JOUR AU - Pechmann, A. AU - Langer, T. AU - Wider, S. AU - Kirschner, J. PY - 2018 DA - 2018// TI - Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1 JO - Eur J Paediatr Neurol EJPN VL - 22 UR - https://doi.org/10.1016/j.ejpn.2017.11.001 DO - 10.1016/j.ejpn.2017.11.001 ID - Pechmann2018 ER - TY - JOUR AU - Aragon-Gawinska, K. AU - Seferian, A. M. AU - Daron, A. AU - Gargaun, E. AU - Vuillerot, C. AU - Cances, C. PY - 2018 DA - 2018// TI - Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: a cohort study JO - Neurology VL - 91 UR - https://doi.org/10.1212/WNL.0000000000006281 DO - 10.1212/WNL.0000000000006281 ID - Aragon-Gawinska2018 ER - TY - JOUR AU - Michelson, D. AU - Ciafaloni, E. AU - Ashwal, S. AU - Lewis, E. AU - Narayanaswami, P. AU - Oskoui, M. AU - Armstrong, M. J. PY - 2018 DA - 2018// TI - Evidence in focus: nusinersen use in spinal muscular atrophy Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology JO - Neurology VL - 91 UR - https://doi.org/10.1212/WNL.0000000000006502 DO - 10.1212/WNL.0000000000006502 ID - Michelson2018 ER - TY - JOUR AU - Vukovic, S. AU - McAdam, L. AU - Zlotnik-Shaul, R. AU - Amin, R. PY - 2019 DA - 2019// TI - Putting our best foot forward: clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy JO - J Paediatr Child Health VL - 55 UR - https://doi.org/10.1111/jpc.14226 DO - 10.1111/jpc.14226 ID - Vukovic2019 ER - TY - STD TI - Finkel R, Bertini E, Muntoni F, Mercuri E; ENMC SMA Workshop Study Group. 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015;25(7):593–602. https://doi.org/10.1016/j.nmd.2015.04.009 ID - ref11 ER - TY - JOUR AU - Dubowitz, V. PY - 1995 DA - 1995// TI - Chaos in the classification of SMA: a possible resolution JO - Neuromuscul Disord VL - 5 UR - https://doi.org/10.1016/0960-8966(94)00075-K DO - 10.1016/0960-8966(94)00075-K ID - Dubowitz1995 ER - TY - JOUR AU - Bishop, K. M. AU - Montes, J. AU - Finkel, R. S. PY - 2018 DA - 2018// TI - Motor milestone assessment of infants with spinal muscular atrophy using the hammersmith infant neurological Exam-Part 2: experience from a nusinersen clinical study JO - Muscle Nerve VL - 57 UR - https://doi.org/10.1002/mus.25705 DO - 10.1002/mus.25705 ID - Bishop2018 ER - TY - JOUR AU - Benini, F. AU - Salamon, E. AU - Divisic, A. AU - Maghini, I. AU - Agosto, C. PY - 2020 DA - 2020// TI - Acknowledging limits: statistics and the child's quality of life in spinal muscular atrophy JO - J Paediatr Child Health VL - 56 UR - https://doi.org/10.1111/jpc.14959 DO - 10.1111/jpc.14959 ID - Benini2020 ER - TY - JOUR AU - Weise, K. L. AU - Okun, A. L. AU - Carter, B. S. AU - Christian, C. W. PY - 2017 DA - 2017// TI - Committee on Bioethics, Section on Hospice and Palliative Medicine, Committee on Child Abuse and Neglect. Guidance on forgoing life-sustaining medical treatment JO - Pediatrics VL - 140 UR - https://doi.org/10.1542/peds.2017-1905 DO - 10.1542/peds.2017-1905 ID - Weise2017 ER - TY - JOUR AU - King, N. M. P. AU - Bishop, C. E. PY - 2017 DA - 2017// TI - New treatments for serious conditions: ethical implications JO - Gene Ther VL - 24 UR - https://doi.org/10.1038/gt.2017.32 DO - 10.1038/gt.2017.32 ID - King2017 ER -